Evidence map›Paper›PMID 24786600›Full record

ArticleBritish journal of cancer2014

Global methylation levels in peripheral blood leukocyte DNA by LUMA and breast cancer: a case-control study in Japanese women.

A Kuchiba, M Iwasaki, H Ono, Y Kasuga, S Yokoyama, H Onuma, H Nishimura, R Kusama, S Tsugane, T Yoshida

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors.Asian Pacific journal of cancer prevention : APJCP · 2020
    Review
  10. SNHG1 Long Noncoding RNA is Potentially Up-Regulated in Colorectal Adenocarcinoma.Asian Pacific journal of cancer prevention : APJCP · 2020
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

A Kuchiba1] Division of Genetics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Tokyo 104-0045, Japan [2] Department of Biostatistics, National Cancer Center, 5-1-1 Tsukiji, Tokyo 104-0045, Japan.
M IwasakiDivision of Epidemiology and Prevention, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Tokyo 104-0045, Japan.
H OnoDivision of Genetics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Tokyo 104-0045, Japan.
Y KasugaDepartment of Surgery, Nagano Matsushiro General Hospital, 183 Matsushiro, Matsushiro-machi, Nagano 381-1231, Japan.
S YokoyamaDepartment of Breast and Thyroid Surgery, Nagano Red Cross Hospital, 5-22-1 Wakasato, Nagano 380-8582, Japan.
H OnumaDepartment of Breast and Thyroid Surgery, Nagano Red Cross Hospital, 5-22-1 Wakasato, Nagano 380-8582, Japan.
H NishimuraDepartment of Surgery, Nagano Municipal Hospital, 1333-1 Tomitake, Nagano 381-8551, Japan.
R KusamaDepartment of Surgery, Nagano Hokushin General Hospital, 1-5-63 Nishi, Nagano 383-8505, Japan.
S TsuganeDivision of Epidemiology and Prevention, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Tokyo 104-0045, Japan.
T YoshidaDivision of Genetics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Tokyo 104-0045, Japan.
Nagano Red Cross Hospital · JPHokushin General Hospital · JPNagano Matsushiro General Hospital · JPNagano Municipal Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlobal hypomethylation has been suggested to cause genomic instability and lead to an increased risk of cancer. We examined the association between the global methylation level of peripheral blood leukocyte DNA and breast cancer among Japanese women.

methodsWe conducted a hospital-based case-control study of 384 patients aged 20-74 years with newly diagnosed, histologically confirmed invasive breast cancer, and 384 matched controls from medical checkup examinees in Nagano, Japan. Global methylation levels in leukocyte DNA were measured by LUminometric Methylation Assay. Odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between global hypomethylation and breast cancer were estimated using a logistic regression model.

resultsCompared with women in the highest tertile of global methylation level, ORs for the second and lowest tertiles were 1.87 (95% CI=1.20-2.91) and 2.86 (95% CI=1.85-4.44), respectively. Global methylation levels were significantly lower in cases than controls, regardless of the hormone receptor status of the cancer (all P values for trend <0.05).

interpretationThese findings suggest that the global methylation level of peripheral blood leukocyte DNA is low in patients with breast cancer and may be a potential biomarker for breast cancer risk.

Indexed as

DNA MethylationAdultAgedBreast NeoplasmsCarcinoma, Ductal, BreastCase-Control StudiesCpG IslandsFemaleHumansJapanLeukocytes, MononuclearMiddle AgedMolecular Diagnostic TechniquesPolymorphism, Single NucleotideRiskYoung Adult

Identifiers

PMID24786600
PMCPMC4037832
OpenAlexW2056389138

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.